1
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Sedimentation of an RNA Polymerase Complex from Vaccinia Virus that Specifically Initiates and Terminates Transcription

&
Pages 7-14 | Received 09 Jun 1986, Accepted 29 Sep 1986, Published online: 31 Mar 2023

LITERATURE CITED

  • Abdel-Monem, M., H. M. Arthur, I. Benz, H. Hoffmann-Berling, A. Seiter, and G. Taucher-Scholz. 1984. Functions of DNA helicases in the DNA metabolism of Escherichia coli. Proteins involved in DNA replication. Adv. Exp. Med. Biol. 179:385–395.
  • Barbosa, E., and B. Moss. 1978. mRNA (nucleoside-2′-)meth- yltransferase from vaccinia virus: purification and physical properties. J. Biol. Chem. 253:7692–7697.
  • Baroudy, B. M., and B. Moss. 1980. Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions. J. Biol. Chem. 255:4372–4380.
  • Bauer, W. R., E. C. Ressner, J. R. Kates, and J. V. Patzke. 1977. A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties. Proc. Natl. Acad. Sci. USA 74:1841–1845.
  • Broyles, S. S., and B. Moss. 1986. Homology between RNA polymerases of poxviruses, prokaryotes and eukaryotes: nucleotide sequence and transcriptional analysis of Mr 147,000 and 22,000 subunit genes of vaccinia virus. Proc. Natl. Acad. Sci. USA 83:3141–3145.
  • Cochran, M. A., C. Puckett, and B. Moss. 1985. In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory sequences. J. Virol. 54:30–37.
  • Erickson, P. F., L. N. Minier, and R. S. Lasher. 1982. Quantitative electrophoretic transfer of polypeptides from SDS polyacrylamide gels to nitrocellulose sheets. J. Immunol. Methods 51:241–249.
  • Foglesong, P. D. 1985. In vitro transcription of a cloned vaccinia virus gene by a soluble extract prepared from vaccinia virus- infected HeLa cells. J. Virol. 53:822–826.
  • Foglesong, P. D., and W. R. Bauer. 1984. Effects of ATP and inhibitory factors on the activity of vaccinia virus type I topoisomerase. J. Virol. 49:1–8.
  • Gershowitz, A., R. F. Boone, and B. Moss. 1978. Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (β, γim- ido)triphosphate. J. Virol. 27:399–408.
  • Golini, F., and J. R. Kates. 1985. A soluble transcription system derived from purified vaccinia virions. J. Virol. 53:205–213.
  • Gottesfeld, J. M. 1986. Novobiocin inhibits RNA polymerase III transcription in vitro by a mechanism distinct from DNA topoisomerase II. Nucleic Acids Res. 14:2075–2088.
  • Joklik, W. K. 1962. The preparation and characteristics of highly purified radioactively labeled poxvirus. Biochim. Biophys. Acta 61:290–301.
  • Kleiman, J. H., and B. Moss. 1975. Purification of a protein kinase and two phosphate acceptor proteins from vaccinia virions. J. Biol. Chem. 250:2420–2429.
  • Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680–685.
  • Martin, S. A., E. Paoletti, and B. Moss. 1975. Purification of mRNA guanylyltransferase and mRNA (guanine-7-)methyltrans- ferase from vaccinia virus. J. Biol. Chem. 250:9322–9329.
  • Messing, J. 1983. New M13 vectors for cloning. Methods Enzymol. 101:20–77.
  • Morrison, D. K., and R. W. Moyer. 1986. Detection of a subunit of cellular pol II with highly purified preparations of RNA polymerase isolated from rabbit poxvirus virions. Cell 44:587–596.
  • Moss, B., E. N. Rosenblum, and A. Gershowitz. 1975. Characterization of a polyriboadenylate polymerase from vaccinia virions. J. Biol. Chem. 250:4722–4729.
  • Nevins, J. R., and W. K. Joklik. 1977. Isolation and properties of the vaccinia virus DNA-dependent RNA polymerase. J. Biol. Chem. 252:6930–6938.
  • Paoletti, E., N. Cooper, and B. Moss. 1974. Regulation of synthesis of two immunologically distinct nucleic aciddependent nucleoside triphosphate phosphohydrolases in vaccinia virus-infected HeLa cells. J. Virol. 14:578–586.
  • Paoletti, E., and B. Moss. 1974. Two nucleic acid-dependent nucleoside triphosphate phosphohydrolases from vaccinia virus: nucleotide substrate and polynucleotide cofactor specificities. J. Biol. Chem. 249:3281–3286.
  • Paoletti, E., H. Rosemond-Hornbeak, and B. Moss. 1974. Two nucleic acid-depedent nucleoside triphosphate phosphohydrolases from vaccinia: purification and characterization. J. Biol. Chem. 249:3273–3280.
  • Puckett, C., and B. Moss. 1983. Selective transcription of vaccinia virus genes in template dependent soluble extracts of infected cells. Cell 35:441–448.
  • Rohrmann, G., and B. Moss. 1985. Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions. J. Virol. 56:349–355.
  • Rohrmann, G., L. Yuen, and B. Moss. 1986. Transcription of vaccinia virus early genes by enzymes isolated from vaccinia virions terminates downstream of a regulatory sequence. Cell 46:1029–1035.
  • Rosemond-Hornbeak, H., E. Paoletti, and B. Moss. 1974. Singlestranded deoxyribonucleic acid specific nuclease from vaccinia virus: purification and characterization. J. Biol. Chem. 249:3287–3296.
  • Sarih, L., M. Garret, H. Aoyama, P. V. Graves, L. Tarrago-Litvak, and S. Litvak. 1983. The in vitro inhibition of DNA polymerase alpha and avian reverse transcriptase by novobiocin. Biochem. Int. 7:79–88.
  • Sawadogo, M., and R. G. Roeder. 1984. Energy requirement for specific transcription initiation by the human RNA polymerase II system. J. Biol. Chem. 259:5321–5326.
  • Shuman, S., and J. Hurwitz. 1981. Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzyme-guanylate intermediate. Proc. Natl. Acad. Sci. USA 78:187–191.
  • Shuman, S., E. Spencer, H. Furneaux, and J. Hurwitz. 1980. The role of ATP in in vitro vaccinia virus RNA synthesis. J. Biol. Chem. 255:5396–5403.
  • Shuman, S., M. Surks, H. Furneaux, and J. Hurwitz. 1980. Purification and characterization of a GTP-pyrophosphate exchange activity from vaccinia virions. Association of the GTP- pyrophosphate exchange activity with vaccinia mRNA guanylyItransferase-RNA (guanine-7-)methyltransferase complex (capping enzyme). J. Biol. Chem. 255:11588–11598.
  • Spencer, E., S. Shuman, and J. Hurwitz. 1980. Purification and properties of vaccinia virus DNA-dependent RNA polymerase. J. Biol. Chem. 255:5388–5395.
  • Sumiyoshi, Y., T. Nishikawa, T. Watanabe, and K. Kano. 1983. Inhibition of retrovirus RNA-dependent DNA polymerase by novobiocin and nalidixic acid. J. Gen. Virol. 64:2329–2333.
  • Venkatesan, S., A. Gershowitz, and B. Moss. 1980. Modification of the 5′ end of mRNA: association of RNA triphosphatase with the RNA guanylyltransferase-RNA (guanine-7-)methyltrans- ferase complex from vaccinia virus. J. Biol. Chem. 255:903–908.
  • Venkatesan, S., A. Gershowitz, and B. Moss. 1982. Complete nucleotide sequences of two adjacent early vaccinia virus genes located within the inverted terminal repetition. J. Virol. 44:637–646.
  • Vieira, J., and J. Messing. 1982. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19:259–268.
  • Wingender, E., D. Jahn, and K. H. Seifart. 1986. Association of RNA polymerase III with transcription factors in the absence of DNA. J. Biol. Chem. 261:1409–1413.
  • Yuen, L., and B. Moss. 1986. Multiple 3′ ends of mRNA encoding vaccinia virus factor occur within a series of repeated sequences downstream of T clusters. J. Virol. 60:320–323.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.